METHODS FOR THE TREATMENT OR PREVENTION OR SCARS AND/OR KELOIDS
    24.
    发明申请
    METHODS FOR THE TREATMENT OR PREVENTION OR SCARS AND/OR KELOIDS 有权
    治疗或预防或治疗和/或康复的方法

    公开(公告)号:US20090131845A1

    公开(公告)日:2009-05-21

    申请号:US12358162

    申请日:2009-01-22

    IPC分类号: A61F13/00

    摘要: Devices, bandages, kits and methods are described that can control or regulate the mechanical environment of a wound to ameliorate scar and/or keloid formation. The mechanical environment of a wound includes stress, strain, and any combination of stress and strain. The control of a wound's mechanical environment can be active, passive, dynamic, or static. The devices are configured to be removably secured to a skin surface in proximity to the wound site and shield the wound from endogenous and/or exogenous stress.

    摘要翻译: 描述了可以控制或调节伤口的机械环境以改善瘢痕和/或瘢痕疙瘩形成的装置,绷带,试剂盒和方法。 伤口的机械环境包括应力,应变和应力和应变的任何组合。 创伤的机械环境的控制可以是主动的,被动的,动态的或静态的。 这些装置被构造成可移除地固定到靠近伤口部位的皮肤表面,并且将伤口屏蔽内源性和/或外源性应激。

    Use of fibromodulin to prevent or reduce dermal scarring
    25.
    发明授权
    Use of fibromodulin to prevent or reduce dermal scarring 失效
    使用纤维调节素预防或减少皮肤瘢痕形成

    公开(公告)号:US5654270A

    公开(公告)日:1997-08-05

    申请号:US303238

    申请日:1994-09-08

    摘要: The present invention provides a method of inhibiting an activity of a cell regulatory factor which includes contacting the cell regulatory factor with a purified polypeptide, the polypeptide including the cell regulatory factor binding domain of a protein which is characterized by a leucine-rich repeat of about 24 amino acids. The present invention relates to the ability of decorin, a 40,000 dalton protein that usually carries a glycosaminoglycan chain, to bind TGF-.beta.. The invention also provides a novel cell regulatory factor designated MRF. Also provided are methods of identifying, detecting and purifying cell regulatory factors and proteins which bind and affect the activity of cell regulatory factors. The present invention further relates to methods for the prevention or reduction of scarring by administering decorin or a functional equivalent of decorin to a wound. The methods are particularly useful for dermal wounds resulting from burns, injuries or surgery. In addition, the present invention includes pharmaceutical compositions containing decorin or its functional equivalent and a pharmaceutically acceptable carrier useful in such methods. Finally, methods for preventing or inhibiting pathological conditions by administering decorin are also provided.

    摘要翻译: 本发明提供了抑制细胞调节因子活性的方法,其包括使细胞调节因子与纯化的多肽接触,所述多肽包括蛋白质的细胞调节因子结合结构域,其特征在于富含亮氨酸重复的约 24个氨基酸。 本发明涉及核心蛋白聚糖(通常携带糖胺聚糖链的40,000道尔顿蛋白)结合TGF-β的能力。 本发明还提供了称为MRF的新型细胞调节因子。 还提供鉴定,检测和纯化结合并影响细胞调节因子活性的细胞调节因子和蛋白质的方法。 本发明还涉及通过给予伤口的核心蛋白聚糖或核心蛋白聚糖的功能等同物来预防或减少瘢痕形成的方法。 这些方法对于由烧伤,损伤或手术引起的皮肤伤口特别有用。 此外,本发明包括含有核心蛋白聚糖蛋白聚糖或其功能等同物的药物组合物和可用于这些方法的药学上可接受的载体。 最后,还提供了通过管理核心蛋白聚糖来预防或抑制病理状况的方法。